Ovary adenocarcinoma tissue array

Ovary adenocarcinoma tissue array 

To Order Contact us: lieven@wlsolutions.be

Lung adenocarcinoma tissue array

LC641 each
EUR 198
Description: Lung adenocarcinoma tissue array, including pathology grade, TNM/Stage, 64 cases/ 64 cores

Lung adenocarcinoma tissue array

LC706a each
EUR 306
Description: Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 75 cases/75 cores, replaced by LC706a

Lung adenocarcinoma tissue array

LC706b each
EUR 306
Description: Lung adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores, replacing LC706a

Colon adenocarcinoma tissue array

CO1251 each
EUR 270
Description: Colon adenocarcinoma tissue array, including ulcer, uplift and infiltrating type adenocarcinoma, with pathology grade, TNM/Stage ( AJCC 8th edition) and MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 125 cases/125cores (core size 1.5mm), Recent Year Collection

Colon adenocarcinoma tissue array

CO1501 each
EUR 258
Description: Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores

Colon adenocarcinoma and rectum adenocarcinoma tissue array

GI1701 each
EUR 414
Description: Colon adenocarcinoma and rectum adenocarcinoma tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 85 cases/170 cores (1.0mm), replacing BC000110

Rectum adenocarcinoma tissue array

RE1501 each
EUR 258
Description: Rectum adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores

Stomach adenocarcinoma tissue array

BS01011b each
EUR 270
Description: Stomach adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BS01011a

Stomach adenocarcinoma tissue array

ST1502 each
EUR 258
Description: Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores

Colon adenocarcinoma and metastatic adenocarcinoma tissue array

CO953a each
EUR 1434
Description: Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953

Colon adenocarcinoma tissue array with colon tissue

CO1201 each
EUR 348
Description: Colon adenocarcinoma tissue array with colon tissue, with pathology grade, TNM/Stage, 120 cases/120 cores (core size 1.0mm), replacing BC051110c

Prostate adenocarcinoma test tissue array

T191b each
EUR 66
Description: Prostate adenocarcinoma test tissue array, with prostate control tissues, pathology grade, TNM and clinical stage (AJCC 8.0), 6 cases/24 cores, replacing T191a (1.5mm)

Lymphatic metastatic adenocarcinoma tissue array

LY803 each
EUR 306
Description: Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores

Colon adenocarcinoma (grade I) tissue array

CO351a each
EUR 168
Description: Colon adenocarcinoma (grade I) tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores, replacing CO351

Colon adenocarcinoma stage IV tissue array

CO489a each
EUR 198
Description: Colon adenocarcinoma stage IV tissue array, including TNM, clinical stage and pathology grade, non-overlapping with other CO489, 24 cases/ 48 cores

Colon adenocarcinoma (grade II) tissue array

CO963a each
EUR 258
Description: Colon adenocarcinoma (grade II) tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing CO963

Lung adenocarcinoma with lung tissue array

LC402 each
EUR 270
Description: Lung adenocarcinoma with lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 30 cases/40 cores (core size 1.5mm)

Colon adenocarcinoma (grade III) tissue array

CO353 each
EUR 168
Description: Colon adenocarcinoma (grade III) tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores, replaced by CO353a

Colon adenocarcinoma (grade III) tissue array

CO353a each
EUR 168
Description: Colon adenocarcinoma (grade III) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores, replacing CO353

Colon adenocarcinoma with colon tissue array

CO483b each
EUR 198
Description: Colon adenocarcinoma with colon tissue array, including pathology, TNM and clinical stage, 48 cases/48 cores, replacing CO483a

Normal lung tissue array with adenocarcinoma tissue as control

LCN721 each
EUR 258
Description: Normal lung tissue array with adenocarcinoma tissue as control, including TNM, clinical stage, pathology grade and IHC result, 24 cases/ 72 cores

Esophagus adenocarcinoma and normal tissue array

ES8011b each
EUR 306
Description: Esophagus adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores (1.5mm), replacing ES8011a

Endometrioid adenocarcinoma and normal tissue array

T091a each
EUR 48
Description: Endometrioid adenocarcinoma and normal tissue array, including pathology grade, TNM/Stage (AJCC 8.0), 6 cases/24 cores (core size 1.5mm), replacing T091

Pancreatic adenocarcinoma with pancreas tissue array

PA1001c each
EUR 306
Description: Pancreatic adenocarcinoma with pancreas tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 50 cases/100 cores, replacing PA1001b

Pancreatic adenocarcinoma with pancreas tissue array

PA484a each
EUR 168
Description: Pancreatic adenocarcinoma with pancreas tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores (core size2.0mm), replacing PA484

Rectum adenocarcinoma tissue array with matched adjacent rectum tissue

RE483 each
EUR 168
Description: Rectum adenocarcinoma tissue array with matched adjacent rectum tissue, including TNM and pathology grade, 16 cases/48 cores

Lung mucin-producing adenocarcinoma (MPA) tissue array

LC822 each
EUR 354
Description: Lung mucin-producing adenocarcinoma (MPA) tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 40 case/80 cores (1.5mm)

Tissue array of rectal adenocarcinoma and matched adjacent tissue

RE481 each
EUR 168
Description: Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases/48 cores

Colonic adenocarcinoma and matched adjacent tissue array

CO481 each
EUR 198
Description: Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases/48 cores

Stomach adenocarcinoma with matched stomach tissue array

ST781 each
EUR 270
Description: Stomach adenocarcinoma with matched stomach tissue array, including pathology grade, TNM and clinical stage, 26 cases/78 cores

Lung invasive adenocarcinoma (2015 WHO classification) tissue array

LC963 each
EUR 348
Description: Lung invasive adenocarcinoma (2015 WHO classification) tissue array, including pathology grade, TNM and clinical stage(AJCC 8.0), 48 cases/96 cores (1.5mm), replacing BCS04017b

Lung adenocarcinoma tissue array with normal lung tissue (2015 WHO classification)

BC04119b each
EUR 270
Description: Lung adenocarcinoma tissue array with normal lung tissue (2015 WHO classification), including pathology grade, TNM and clinical stage,30 cases/40 cores, replacing BC04119a

Moderately differentiated adenocarcinoma of colon tissue array

CO352a each
EUR 168
Description: Moderately differentiated adenocarcinoma of colon tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores

Colon adenocarcinoma with matched adjacent colon tissue array

CO487 each
EUR 168
Description: Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases/48 cores

Stomach adenocarcinoma with matched adjacent normal tissue array

ST1004a each
EUR 258
Description: Stomach adenocarcinoma with matched adjacent normal tissue array, including TNM and pathology grade, 55 cases/100 cores(1.0mm), replacing ST1004

Prostate adenocarcinoma with hyperplasia and prostate tissue array

PR1211 each
EUR 563
Description: Prostate adenocarcinoma with hyperplasia and prostate tissue array, including pathology grade, TNM, clinical stage (AJCC 8.0), Gleason grade and Gleason score, 121 cases/121 cores

Lung adenocarcinoma with matched adjacent normal lung tissue array

LC10013c each
EUR 306
Description: Lung adenocarcinoma with matched adjacent normal lung tissue array, including pathology grade, TNM and clinical stage, 52 cases/100 cores, replacing LC10013b

Advanced stage of stomach adenocarcinoma with stomach tissue array

ST963a each
EUR 306
Description: Advanced stage of stomach adenocarcinoma with stomach tissue array, including pathology grade, TNM and clinical stage, 95 cases/95 cores, replacing ST963

Gallbladder adenocarcinoma with adjacent normal gallbladder tissue array

GA751a each
EUR 270
Description: Gallbladder adenocarcinoma with adjacent normal gallbladder tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores (core size 1.5mm), replacing GA751

Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control

CO722 each
EUR 270
Description: Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases/72 cores, replacing BC05021

Progressive colon adenocarcinoma with matched cancer adjacent tissue array

CO1507 each
EUR 306
Description: Progressive colon adenocarcinoma with matched cancer adjacent tissue array, including ulcer, uplift and infiltrating type adenocarcinoma, with pathology grade, TNM/Stage ( AJCC 8th edition) and MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 75 cases/150cores (core size 1.0mm), Recent Year Collection

Colon poorly differentiated adenocarcinoma and adjacent normal tissue array

CO725 each
EUR 270
Description: Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases/72 cores, replacing BS05041

Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores

PR806 each
EUR 306
Description: Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases/80 cores

Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info

PA803 each
EUR 306
Description: Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info, 40 cases/80 cores

Lung adenocarcinom tissue array

LC641b each
EUR 198
Description: Lung adenocarcinom tissue array, including invasive papillary adenocarcinoma, invasive mucinous adenocarcinoma and invasive adenocarcinoma with pathology grade, TNM and clinical stage, 64 cases/64 cores, (core size 1.5mm), replacing LC641a

Pancreatic ductal adenocarcinoma(PDAC) tissue array with 4 normal tissue control from autopsy

PA482 each
EUR 138
Description: Pancreatic ductal adenocarcinoma(PDAC) tissue array with 4 normal tissue control from autopsy, 24 cases/48 cores, with TNM data

Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data

ST721 each
EUR 306
Description: Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases/72 cores.

Lung adenocarcinoma (grade III) with adjacent normal lung tissue array (2015 WHO classification)

BS04081a each
EUR 138
Description: Lung adenocarcinoma (grade III) with adjacent normal lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 21 cases/63 cores, replacing BS04081

Small intestine(most of duodenum) adenocarcinoma tissue array with matched NAT or AT as control

SM1501 each
EUR 258
Description: Small intestine(most of duodenum) adenocarcinoma tissue array with matched NAT or AT as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores

Lung adenocarcinoma with matched normal adjacent or cancer adjacent lung tissue array

LC1531 each
EUR 258
Description: Lung adenocarcinoma with matched normal adjacent or cancer adjacent lung tissue array, including pathology grade, TNM/Stage (AJCC 8th edition), 51 cases/153 cores (core size 1.0mm), replacing LC1504

Lung adenocarcinoma with matched cancer adjacent or adjacent normal lung tissue array

LC992a each
EUR 270
Description: Lung adenocarcinoma with matched cancer adjacent or adjacent normal lung tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/99 cores, replacing LC992

Pancreatic ductal adenocarcinomas (PDAs) with pancres tissue array

PA243c each
EUR 270
Description: Pancreatic ductal adenocarcinomas (PDAs) with pancres tissue array, including perineural invasion info and pathology grade, TNM and clinical stage, 24 cases/48 cores, replacing PA243b

Pancreatic adenocarcinoma with matched adjacent normal or cancer adjacent pancreas tissue array

PA601 each
EUR 281
Description: Pancreatic adenocarcinoma with matched adjacent normal or cancer adjacent pancreas tissue array, including pathology, TNM and clinical stage (reference AJCC 8th version), 37 cases/60 cores

Lung Tissue Slide (Adenocarcinoma)

10-106-10um 10 um
EUR 241.8

Lung Tissue Slide (Adenocarcinoma)

10-106-4um 4 um
EUR 216.6

Stomach adenocarcinoma tissue microarray

ST991b each
EUR 270
Description: Stomach adenocarcinoma tissue microarray, including TNM, clinical stage and pathology grade, 33 cases/ 99cores, replacing ST991a

Uterus Tissue Slide (Adenocarcinoma)

11-404-10um 10 um
EUR 241.8

Uterus Tissue Slide (Adenocarcinoma)

11-404-4um 4 um
EUR 216.6

Stomach Tissue Slide (Adenocarcinoma)

10-809-10um 10 um
EUR 241.8

Stomach Tissue Slide (Adenocarcinoma)

10-809-4um 4 um
EUR 216.6

Pancreas Tissue Slide (Adenocarcinoma)

11-105-10um 10 um
EUR 241.8

Pancreas Tissue Slide (Adenocarcinoma)

11-105-4um 4 um
EUR 216.6

Colorectal Tissue Slide (Adenocarcinoma)

10-704-10um 10 um
EUR 241.8

Colorectal Tissue Slide (Adenocarcinoma)

10-704-4um 4 um
EUR 216.6

Colorectal Tissue Slide (Adenocarcinoma)

RF10002-06-10um 10 um
EUR 241.8

Colorectal Tissue Slide (Adenocarcinoma)

RF10002-06-4um 4 um
EUR 216.6

Small Intestine Tissue Slide (Adenocarcinoma)

11-815-10um 10 um
EUR 241.8

Small Intestine Tissue Slide (Adenocarcinoma)

11-815-4um 4 um
EUR 216.6

Stomach Tissue Slide (mucinous Adenocarcinoma)

10-810-10um 10 um
EUR 241.8

Stomach Tissue Slide (mucinous Adenocarcinoma)

10-810-4um 4 um
EUR 216.6

Uterus Tissue Slide (Endometrioid Adenocarcinoma)

11-405-10um 10 um
EUR 241.8

Uterus Tissue Slide (Endometrioid Adenocarcinoma)

11-405-4um 4 um
EUR 216.6

Uterus Tissue Slide ( Papillary serous Adenocarcinoma)

11-407-10um 10 um
EUR 241.8

Uterus Tissue Slide ( Papillary serous Adenocarcinoma)

11-407-4um 4 um
EUR 216.6

Stomach Tissue Slide (Signet Ring Cell Adenocarcinoma)

10-811-10um 10 um
EUR 241.8

Stomach Tissue Slide (Signet Ring Cell Adenocarcinoma)

10-811-4um 4 um
EUR 216.6

Human Uterus Tissue Slide (Adenocarcinoma) (5 slides/pk)

HTS-11404 1 pk
EUR 343.2

Human Stomach Tissue Slide (Adenocarcinoma) (5 slides/pk)

HTS-10809 1 pk
EUR 343.2

Paraffin Tissue Section - Human Lung Tumor: Adenocarcinoma

T2235152-1 5 slides
EUR 238

Human Pancreas Tissue Slide (Adenocarcinoma) (5 slides/pk)

HTS-11105 1 pk
EUR 343.2

Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma

T2235090-1 5 slides
EUR 238

Paraffin Tissue Section - Human Liver Tumor: Adenocarcinoma

T2235149-1 5 slides
EUR 238

Paraffin Tissue Section - Human Appendix Tumor: Adenocarcinoma

T2235006-1 5 slides
EUR 238

Paraffin Tissue Section - Human Pancreas Tumor: Adenocarcinoma

T2235188-1 5 slides
EUR 238

Paraffin Tissue Section - Human Prostate Tumor: Adenocarcinoma

T2235201-1 5 slides
EUR 238

Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma, MSH

T2235090MSH 5 slides
EUR 734

Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma, MSS

T2235090MSS 5 slides
EUR 524

Paraffin Tissue Section - Human Rectum Tumor: Adenocarcinoma, MSS

T2235206MSS 5 slides
EUR 524

Paraffin Tissue Section - Human Uterus Tumor: Adenocarcinoma, MSS

T2235274MSS 5 slides
EUR 524

Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma (Ulcer)

T2235090-3 5 slides
EUR 238

Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, MSS

T2235248MSS 5 slides
EUR 524

Human Stomach Tissue Slide (Mucinous adenocarcinoma) (5 slides/pk)

HTS-10810 1 pk
EUR 343.2

Paraffin Tissue Section - Human Breast Tumor: Mucous Adenocarcinoma

T2235086-6 5 slides
EUR 238

Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma (Mucoid)

T2235090-2 5 slides
EUR 238

Human Uterus Tissue Slide (Endometrioid Adenocarcinoma) (5 slides/pk)

HTS-11405 1 pk
EUR 343.2

Paraffin Tissue Section - Human Thyroid Tumor: Papillary Adenocarcinoma

T2235265-7 5 slides
EUR 238

Human Uterus Tissue Slide (Papillary serous Adenocarcinoma) (5 slides/pk)

HTS-11407 1 pk
EUR 343.2

Paraffin Tissue Section - Human Uterus Tumor: Endometrium Adenocarcinoma

T2235274-3 5 slides
EUR 238

Human Stomach Tissue Slide (Signet Ring Cell Adenocarcinoma) (5 slides/pk)

HTS-10811 1 pk
EUR 343.2

Paraffin Tissue Section - Human Small Intestine Tumor: Duodenum Adenocarcinoma

T2235226-1 5 slides
EUR 238

Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, Well Differentiated

T2235248-3 5 slides
EUR 238

Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma Poorly Differentiated

T2235248-1 5 slides
EUR 238

Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Poorly Differentiated

T2235118-2 5 slides
EUR 238

Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Well Differentiated

T2235118-3 5 slides
EUR 238

Paraffin Tissue Section - Human Pancreas Tumor: Adenocarcinoma, Moderately Differentiated

T2235188-2 5 slides
EUR 238

Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, Moderately Differentiated

T2235248-2 5 slides
EUR 238

Rectum adenocarcinoma with normal and adjacent rectum tissues

REF482 each
EUR 144
Description: Rectum adenocarcinoma with normal and adjacent rectum tissues, recent years collection, including pathology grade, TNM and clinical stage ( AJCC 8th Edition), 45 cases/48 cores, replacing RE482

Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Moderately Differentiated

T2235118-1 5 slides
EUR 238

Lung large cell carcinoma and adenocarcioma tissue array

LC805a each
EUR 222
Description: Lung large cell carcinoma and adenocarcioma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing LC805

Prostate adenocarcinoma

PR781 each
EUR 306
Description: Prostate adenocarcinoma, hyperplasia, NAT and normal tissue array, including pathology grade, TNM/Stage (AJCC 8.0), Gleason grade, Gleason score, 78 cases/78 cores (core size 1.5mm), replacing PR807c.

Colon adenocarcinoma TMA

CO571 each
EUR 270
Description: Colon adenocarcinoma TMA, 5 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version) with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 52 cases/ 57 cores (core size 1.5mm) Recent Year Collection

Human Lung Adenocarcinoma

HS0033 6 Slides/Pack
EUR 160

Human Colon Adenocarcinoma

HS0022 6 Slides/Pack
EUR 160

Human Rectal Adenocarcinoma

HS0025 6 Slides/Pack
EUR 160

Human Stomach Adenocarcinoma

HS0026 6 Slides/Pack
EUR 160

Human Lung Adenocarcinoma CAFs

CAF07A 1,000,000 cells
EUR 1492.8

Progressive colon adenocarcinoma

CO1506 each
EUR 258
Description: Progressive colon adenocarcinoma, matched cancer adjacent with normal adjacent tissue array, including pathology grade, TNM /Stage ( AJCC 8th version) and MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 50 cases/150cores (core size 1.0mm),Recent Year Collection

HeLa – Human Cervix Adenocarcinoma

72-XXXX each Ask for price
Description: Single or Mixed

Human Endometrioid Adenocarcinoma

HS0044 6 Slides/Pack
EUR 160

HeLa 229 – Human Cervix Adenocarcinoma

75-XXXX each Ask for price
Description: Single or Mixed

CA 15-3, Human Breast Adenocarcinoma

P1435-1 each
EUR 130.8

CA 15-3, Human Breast Adenocarcinoma

P1435-5 each
EUR 288

Human Endometrial Adenocarcinoma CAFs

CAF01 1,000,000 cells
EUR 1467.6

Human MCF7 (Breast Adenocarcinoma) lysate

HCL-1219 1 mg
EUR 628.8

Human PC-3 (Prostate Adenocarcinoma) lysate

HCL-1216 100ug
EUR 285.6

Human Lung Slide (Adenocarcinoma) (5 slides/pk)

HTS-10106 1 pk
EUR 343.2

Human SW480 (Colorectal Adenocarcinoma) lysate

HCL-1221 100ug
EUR 285.6

Human HT-29 (Colorectal Adenocarcinoma) lysate

HCL-1218 100ug
EUR 285.6

Cancer Antigen 125 Antigen (Human Adenocarcinoma)

VAng-Cr3868-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography.

Human Caco-2 (Colorectal Adenocarcinoma) lysate

HCL-1223 100ug
EUR 285.6

GFP-Expressing Human Colorectal Adenocarcinoma (LS 174T)

ABC-RC215D 1 vial Ask for price
Description: Human Colorectal Adenocarcinoma (LS 174T) cells are isolated from a Dukes type B colorectal adenocarcinoma tissue by by centrifugal force following enzymatic digestion. GFP-expressing Human Colorectal Adenocarcinoma (GFP-LS 174T) are selected from LS 174T cells after infected with lentiviruses expressing GFP with puromycin. The cells are shipped in a frozen vial with more than 5 x 105 cells/vial. The Universal Full Growth Medium are recommended to culture the cells and these cells have a minimum population doubling capacity > 20 when cultured following the detailed protocol described below.

Human MDA-MB-361 (Breast Adenocarcinoma) lysate

HCL-1217 100ug
EUR 285.6

Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%)

VAng-Cr3869-25kU 25 kU
EUR 967.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186.

Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate

HCL-2009 1 mg
EUR 628.8

Human Colorectal Slide (Adenocarcinoma) (5 slides/pk)

HTS-10704 1 pk
EUR 343.2

Cancer of the lung (adenocarcinoma), 80 cases (1.1mm), set 1

LUC1601 1
EUR 318
Description: Lung cancer tissue array (adenocarcinoma), 160 cores from normal (3 cases) and various types of adenocarcinoma (77 cases with TNM staging data) tissues in duplicates.

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), 0.2mg/mL

BNUB3306-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), 0.2mg/mL

BNUB3306-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), 0.2mg/mL

BNUB3308-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), 0.2mg/mL

BNUB3308-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), 0.2mg/mL

BNUB3309-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), 0.2mg/mL

BNUB3309-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), 1mg/mL

BNUM3306-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), 1mg/mL

BNUM3308-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), 1mg/mL

BNUM3309-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Ovary disease spectrum tissue array

OV1002a each
EUR 306
Description: Ovary disease spectrum tissue array, 99 cases/100 cores, replacing OV1002

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R), 0.2mg/mL

BNUB1865-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R), 0.2mg/mL

BNUB1865-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(NAPSA/1865R), 1mg/mL

BNUM1865-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Napsin A (Lung Adenocarcinoma Marker)(rNAPSA/1239), 1mg/mL

BNUM1880-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cancer Antigen CA-125 Antigen (Human Adenocarcinoma)

VAng-Wyb8642-inquire inquire Ask for price
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL.

GFP Expressing Human Renal Adenocarcinoma Cells (ACHN)

TR04-GFP 500,000 Cells
EUR 1624.8

RFP Expressing Human Renal Adenocarcinoma Cells (ACHN)

TR04-RFP 500,000 Cells
EUR 1624.8

Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract

HCL-2008 100ug
EUR 270

Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238) Antibody

BNUB1238-50 50uL
EUR 486
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238), 1mg/mL

SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), 0.2mg/mL

BNUB2524-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), 0.2mg/mL

BNUB2524-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

SMAD4 (Pancreatic Adenocarcinoma Marker)(SMAD4/2524), 1mg/mL

BNUM2524-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Human Gastric Adenocarcinoma, Peptide Aptamer, unlabeled

AP-314-U 5 mg Ask for price

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC941880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC941880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC801880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC801880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC701880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC701880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC881880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF488A conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC881880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF488A conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC811880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC811880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC051880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC051880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC041880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405S conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC041880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405S conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC401880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF640R conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC401880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF640R conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCAP1880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCAP1880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCA1880-250 250uL
EUR 472.8
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), APC conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCP1880-250 250uL
EUR 472.8
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), PerCP conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCR1880-250 250uL
EUR 472.8
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), RPE conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCH1880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCH1880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCB1880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Biotin conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNCB1880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Biotin conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNUB1880-100 100uL
EUR 316.8
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Concentration: 0.2mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNUB1880-50 50uL
EUR 486
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), 1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNUB1880-500 500uL
EUR 615.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Concentration: 0.2mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC471880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF647 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC471880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF647 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC611880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC611880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC431880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC431880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC551880-100 100uL
EUR 279.6
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody

BNC551880-500 500uL
EUR 654
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL

Ovary adenocarcinoma tissue array